CAMBRIDGE, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, chair and chief executive officer, will be presenting a company overview at the Rodman & Renshaw Annual Global Investment Conference in New York. Infinity's presentation will take place on November 12, 2008 at 11:10 a.m. EST.
